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Abstract
Background: Rab GTPases function as modulators in intracellular transport. Rab5a, a member of the Rab subfamily
of small GTPases, is an important regulator of vesicle traffic from the plasma membrane to early endosomes.
Recent findings have reported that Rab5a gene was involved in the progression of cancer. In the present study, we
investigated the effect of Rab5a on cervical cancer invasion and metastasis and the molecular mechanism
underlying the involvement of Rab5a.
Methods: Rab5a expression was assessed by immunohistochemical analysis on a cervical cancer tissue microarray.
RNA interference (RNAi) was performed to knock down the endogenous expression of Rab5a gene in HeLa and
SiHa cells. Cell motility was evaluated using invasion assay and wound migration assay in vitro. The expression
levels of integrin-associated molecules were detected by Western blot and immunofluorescence.
Results: We found that Rab5a was expressed at a high level in cervical cancer tissues. Silencing of Rab5a
expression significantly decreased cancer cell motility and invasiveness. The down-regulation of integrin-associated
focal adhesion signaling molecules was further detected in Rab5a knockdown cells. Meanwhile, active GTP-bound
Rac1, Cdc42, and RhoA were also down-regulated, accompanied with the reduction in the number and size of
filopodia and lamellipodia.
Conclusions: Taken together, these data suggest that Rab5a functions in regulating the invasion phenotype, and
we propose that this regulation may be via integrin-mediated signaling pathway in cervical cancer cells.
Background
Cancer is a leading cause of mortality worldwide. Inva-
sion and metastasis is the main biological characteristics
of cancer cells, and the major cause of death in patients
with cancer. The investigation concerning tumor cell
invasion and metastasis has become the focus of intense
researches. However, the molecular mechanism of the
progression of cancer cell invasion and metastasis has
not been fully elucidated.
Small GTPases of the Ras superfamily function as
molecular switches that involve in the control of a large
variety intracellular processes, including proliferation
and differentiation, gene expression, signal transduction,
vesicle trafficking, nuclear assembly, and reorganization
of cytoskeleton. Most of these small GTPases cycle
between two forms: an active GTP-bound form and an
inactive GDP-bound form. GTPase activating proteins
(GAPs) promote the GDP-bound state of small GTPases
by activating their intrinsic GTPase activity, while GTP
exchange factors (GEFs) promote the active GTP-bound
state by facilitating the exchange of GDP for GTP. So
far more than 100 members of small GTPases have
been identified in eukaryotes. According to their
sequence ho mology, these proteins are classified into
five groups: the Ras, Rho/Rac/Cdc42, Sar1/Arf, Rab and
Ran subfamilies [1,2]. The Rab GTPases subfamily regu-
lates intracellular vesicle transport, including receptor-
mediated endocytosis, exocytosis, and receptors recy-
cling [3]. Emerging evidence shows aberrant expression
of the Rab GTPases in many human diseases including
cancer [4-6]. Rab5a, a member of the Rab GTPases sub-
family, is mainly localized to the cytosolic face of plasma
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membrane, early endosomes, and clathrin-coated vesi-
cles. It is a key regulator of intracellular vesicle traffic
from the plasma membrane to early endosomes [7,8].
Recent findings have revealed that the overexpression of
Rab5a gene was correlated with the metastatic potential
and malignant degree of lung and stomach cancer
[9,10]. It was also reported that Rab5a was involved in
EGF signaling pathway and migration in hepatocellular
carcinomas [11]. Moreover, Rab5a was proved to be
required for the activation of Rac, a member of the Rho
GTPases subfamily, and involve in the regulation of
actin cytoskeletal organization [12,13].
It is well known that cell to cell and cell to extracellu-
lar matrices (ECM) adhesions affect morphological
changes involved in cell migration. Integrins, a large
family of cell adhesion glycoproteins, mediate the adhe-
sion of cells to ECM and provide traction for cell moti-
lity. The heterodimerization of 19 a-subunits and 8 b-
subunits paired to yield 25 different integrins, which
form transmembrane receptors for a series of ECM
molecules [14]. Each pair of integrin ab heterodimers
has defined extracellular ligands. Meanwhile, many pro-
teins present at the cytoplasmic side of focal adhesions
are considered to link transmembrane receptors to the
actin cytoskeleton. They are classified into two groups:
one is structural proteins, including talin, vinculin, a-
actinin, and tensin etc; the other is regulating molecules,
including paxillin, focal adhesion kinase (FAK) etc.
Moreover, integrins also involve in many cellular pro-
cesses such as gene transcription, proliferation, signal
transduction, and in the progression of diseases such as
cancer. In fact, several integrins have been proved to
show an increased expression pattern in metastatic can-
cers [15,16]. It is clear that endocytic trafficking could
control cell adhesion events, and then affect cell motility
[17-19]. However, the link between Rab5a and integrin-
mediated signaling pathway and the exact roles of Rab5a
in cancer progression remain unclear.
In the present study, we investigated the mechanism
of Rab5a involving in the progression of cervical cancer
cells invasion and metastasis. The results showed that
Rab5a expression was up-regulated in cervical cancer as
compared with paired non-tumorous tissues. Moreover,
the absence of Rab5a expression reduced the levels of
integrin-mediated signaling molecules in cervical cancer




HeLa and SiHa cells (human cervical carcinoma cell
lines) were maintained in DMEM medium supplemen-
ted with 10% fetal calf serum, 2 mM L-glutamine, 100
IU/ml penicillin and 100 μg/ml streptomycin (all from
Invitrogen) at 37°C in a humidified atmosphere of 5%
CO2.
Antibodies and reagents
Antibodies against Rab5a, Rac1, Cdc42, GFP, FAK, pax-
illin, vinculin, GAPDH were obtained from Santa Cruz
Biotechnology, Inc. Antibodies against integrin-b1, p-
FAK (Tyr 397), p-paxillin (Tyr 118) were obtained from
Abcam plc. Linear polyethylenimine (PEI, MW~25000)
was obtained from Polysciences, Inc. Mitomycin C, glu-
taraldehyde, and paraformaldehyde were purchased from
Sigma-Aldrich. FITC-labeled phalloidine and DAPI were
obtained from Invitrogen, Inc. Glutathion-sepharose
beads were obtained from GE Healthcare.
Immunohistochemistry
The detection of Rab5a protein expression was per-
formed with paraffin-embedded cervical cancer tissue
array (Shanghai Outdo Biotech). The slide was dewaxed
in xylene, and rehydrated through graded alcohol to dis-
tilled water. For antigen retrieval the slide was placed in
citrate buffer by heating. Then the slide was immersed
in 3% H2O2 for 10 min to quench endogenous peroxi-
dase, and blocked with 10% rabbit serum in PBS for 30
min. The primary antibody was 1:50 diluted in 1% BSA
in PBS and incubated with the samples at overnight 4°C.
Then the slide was rinsed in PBS, and the HRP-conju-
gated secondary antibody was applied at 37°C for 30
min. After rinsing with PBS, the section was incubated
with DAB for 3 min. Then the slide was counterstained
with 20% hematoxylin, dehydrated in graded ethanol,
cleared in xylene and mounted with permount.
siRNAs preparation and cell transfection
Two siRNAs molecule targeting human Rab5a gene
(Genbank accession number NM_004162) were
designed using the software on Ambion website (siRNA
Target Finder) and correspond to the sequences 5’-CCA
ACCAGGAATCAGTGTT-3’ and 5’-CCACAAAATCCA
GGAGCAA-3’. A non-targeting random siRNA severed
as the negative control, the sequence is 5’-ACTACCG
TTGTTATAGGTG-3’ (Ambion).
Cells were stably transfected with the negative control
siRNA construct (pSilencer4.1-control), or Rab5a-siR-
NAs plasmids (pSilencer4.1-Rab5a-siRNAs) using linear
PEI (MW~25000) respectively. Then the cells were cul-
tured for 3 weeks in 600 μg/ml G418 (Merch).
Wound migration assay
Cells were plated at 5×105 cells/well in 12-well dishes
and incubated overnight yielding confluent monolayers
for wounding. Before an injury line was made using a
pipette tip, cells were pretreated with mitomycin C (25
μg/ml) for 45 min. Then cells were allowed to migrate
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in complete DMEM medium, and photographs were
taken immediately and 16 hr after wounding. Results
were presented as migration index: the distance
migrated by Rab5a-siRNAs cells or Control cells relative
to the width of injured line of Control at 0 hr.
Invasion assay in vitro
In vitro invasion assay was performed in Matrigel Inva-
sion Chamber with 8 μm pores (Becton Dickinson).
Cells were seeded in the upper chamber at 1.2×105
cells/insert. The lower chamber was filled with complete
medium. After incubating for 24 hr, cells were fixed
with methanol and stained with 0.1% crystal violet.
Count the cells that migrated to the lower side of the
membrane under a microscope. Three inserts were
assayed for each sample and fifteen fields were counted
for each insert.
Scanning electron microscopy (SEM)
To observe cellular surface, cells were transferred to
round coverglasses and incubated overnight. Cells were
fixed in PBS containing 2.5% glutaraldehyde and 4% par-
aformaldehyde for 1 hr. Then samples were rinsed with
PBS and postfixed in 1% OsO4 for 1 hr, dehydrated in a
graded series of ethanol, transferred into acetone, and
dried in K850 critical point drier (Emitech). Dried sam-
ples were coated with a thin layer of gold in SCD-005
supercoator (BAL-TEC) for 180 sec, and were examined
under a Quanta 200 scanning electron microscope (FEI)
at 10 kV.
Confocal laser scanning microscopy
Cells were cultured on round coverglasses for 24 hr
(approximately 60% confluence). Then cells were fixed
in PBS containing 4% paraformaldehyde for 30 min, per-
meabilized with 1% Triton X-100 in PBS for 10 min,
washed three times with PBS, and blocked in PBS con-
taining 3% BSA for 1 hr. Cells were incubated with pri-
mary antibodies diluted in blocking buffer for 1 hr. Cells
were then rinsed three times with PBS containing 0.1%
Tween-20 (PBST) and incubated with secondary antibo-
dies. DNA was identified by staining with DAPI for 1
min. The coverglasses were then mounted and examined
using a LSM 510 META confocal microscope (Zeiss).
GST-pull down assay of GTP-bound Rac1, Cdc42, and
RhoA
GST-pull down assays of active GTP-bound Rac1,
Cdc42, and RhoA were performed as described pre-
viously [20] with slight modification. GST-RBD (Raf Ras
binding domain) and GST-TRBD (Rhotekin Rho binding
domain) were expressed by pGEX-RBD and pGEX-
TRBD (gift from Dr. Xiang-Dong Ren) in E. coli strain
Rosetta (DE3) respectively and purified on glutathion-
sepharose beads. Cells were lysed in 50 mM Tris-HCl,
pH 7.4, containing 1% Triton X-100, 150 mM NaCl, 5
mM MgCl2, 1 mM DTT, 10 μg/ml aprotinin, 10 μg/ml
leupeptin, and 1 mM PMSF. Equal amount of cell
lysates were incubated with GST-RBD or GST-TRBD
beads for 60 min at 4°C. GTP-bound Rac1, Cdc42, and
RhoA were detected by Western blotting. The amount
of GTP-bound Rac1, Cdc42, and RhoA was normalized
to the total amount of these GTP-bound GTPases in
cell lysates in each sample separately.
Results
The expression of Rab5a protein is up-regulated in
cervical cancers
To determine the expression pattern of Rab5a protein in
cervical cancer, we analyzed Rab5a expression by immu-
nohistochemistry in primary cervical cancer tissues and
paired adjacent non-tumorous tissues from 31 patients
(62 tissue cores). Rab5a immunostaining was observed
to mainly localize in the cytoplasm and membrane of
cancer cells. Qualitation of the staining was determined
by the percentage of cells showing positive immunoreac-
tivity (0, no staining; 1, <20%; 2, 20-50%; and 3, >50% of
cells), and the intensity of staining (graded 0, negative;
1, weak; 2, moderate; and 3, strong). As shown in Figure
1, Rab5a protein levels observed in tumor were higher
than those observed in adjacent non-tumorous tissues
(P < 0.05). The results indicate that Rab5a may be
involved in the progression of cervical cancer.
Knockdown of Rab5a expression decreases cancer cell
motility and invasiveness
To examine whether Rab5a is relative to the progression
of cancer cell invasion and metastasis in vitro, human
cervical carcinoma HeLa and SiHa cells were stably
transfected with two siRNAs molecule within the coding
sequence of Rab5a gene respectively. Two assays were
used to determine the effects of Rab5a knockdown on
cell motility: a wound migration assay and an in vitro
invasion assay using matrigel-coated chamber. Before
these assays were performed, Rab5a expression was con-
firmed firstly (Figure 2A, upper panel and Figure 3A). In
the case of invasion analyses, knockdown of Rab5a
expression with both siRNAs significantly reduced cell
motility (Figure 2A and 3B, P < 0.05). The Rab5a-siR-
NAs cells that migrated to the lower side of the mem-
brane were threefold lower than Control cells. Wound
migration assay also showed that Rab5a knockdown
cells had decreased motility, as compared with Control
cells (Figure 2B and 3C, P < 0.05). To eliminate the
effect of cell proliferation on migration, cells were pre-
treated with mitomycin C before an injury line was
made [21], and MTT assays carried out over the same
time periods were presented as insets. These results
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suggest that the depletion of Rab5a can decrease cancer
cell invasiveness and motility in vitro.
Rab5a affects integrin-mediated focal adhesion complex
assembly
Since Rab5a has been identified to involve in cancer cell
motility and invasiveness, as described above, we set out
to define the effects of Rab5a knockdown on integrin-
mediated signaling molecules. We chose to examine the
expression levels of integrin b1, FAK, p-FAK (Tyr 397),
paxillin, p-paxillin (Tyr 118), and vinculin by Western
blot and immunofluorescence. The results showed that
all these integrin-mediated signaling proteins, to some
extent, were down-regulated in Rab5a-siRNAs cells, as
compared with Control (Figure 4A and 5A). As expected,
these results were further confirmed by the observation
that immunostained integrin b1 and paxillin in Rab5a-
siRNAs cells were weaker than Control cells (Figure 4B,
C and 5B, C). These data suggest that Rab5a can affect
integrin-associated focal adhesion complex assembly.
Rab5a depletion affects the actin cytoskeletal
reorganization
Since Rab5a has been shown to influent cancer cell
invasiveness and mobility, we focus on the effects of
Rab5a depletion on the actin cytoskeleton organization.
Scanning electron microscopy (SEM) was used to
observe the membrane surface ultrastructure of Control
and Rab5a knockdown cells. The results showed that
knockdown of Rab5a expression with both siRNAs
caused a significant reduction in the number and size of
filopodia and lamellipodia formation, as compared to
Control cells (Figure 6A). Further analyses of phalloidin-
stained cells also revealed that the filopodia and lamelli-
podia formation is obviously inhibited in Rab5a-siRNAs
cells (Figure 6B and 7A), which is consistent with the
changes on membrane surface ultrastructure detected by
SEM. These findings indicate that the absence of Rab5a
causes cancer cell morphologic change by action cytos-
keleton remodeling.
Rab5a depletion decreases active GTP-bound Rac1,
Cdc42, and RhoA
It is necessary to analyze the effects of Rab5a deple-
tion on the activity of Rho GTPases. GST-pull down
assay was performed to detect the active GTP-bound
form of Rac1, Cdc42, or RhoA. GST-RBD was used
for affinity precipitation of endogenous GTP-bound
Rac1 or Cdc42, while GST-TRBD was used to specifi-
cally bind GTP-loaded GFP-tagged RhoA because of
Figure 1 Immunohistochemical staining of Rab5a protein in cervical cancer and paired adjacent non-tumor tissues. The expression of
Rab5a protein is up-regulated in cervical cancer tissues (A), as compared to their paired non-tumor tissues (B). ×400. (C) Plot showing staining
scores on tissue microarray for both tumor tissues and paired non-tumor tissues. *P < 0.05, as determined by Wilcoxon signed-rank test.
Liu et al. Journal of Biomedical Science 2011, 18:58
http://www.jbiomedsci.com/content/18/1/58
Page 4 of 9
the lower expression level of endogenous RhoA in
HeLa and SiHa cells. The results revealed that the
active conformation of GTP-bound Rac1, Cdc42, and
RhoA were significantly down-regulated in Rab5a-siR-
NAs cells (Figure 6C and 7B). These findings impli-
cate that Rab5a has a marked influence on the
activation of Rho GTPases. Moreover, these findings
explain the observation of actin remodeling in Rab5a-
siRNAs cells.
Discussion
Rab5a is best known as an important regulator of intra-
cellular vesicle transport, while little is known in detail
about the pathophysiological role of Rab5a in human
diseases. Only a few studies have shown that Rab5a was
involved in the progression of cancer. However, the
exact role of Rab5a in cancer cell invasion and metasta-
sis is still unknown. In this paper, we confirmed that
Rab5a protein was over expressed in cervical cancer
compared to the paired non-tumorous tissues. To
further identify the role of Rab5a in cancer cell motility
and invasiveness, RNAi was used to knock down the
expression of endogenous Rab5a in HeLa and SiHa
cells. We observed that the depletion of Rab5a not only
decreased cancer cell motility and invasiveness, but also
inhibited the formation of filopodia and lamellipodia
protrusions. These findings suggest that Rab5a may
involve in the progression of cancer cell invasion and
metastasis by regulating the actin cytoskeleton remodel-
ing. Further studies were mainly focused on the down-
stream targets of Rab5a.
Cell migration and invasion are essential processes in
the metastasis of cancer cells. Migratory cancer cells
undergo series of morphological changes by the recon-
struction of adhesion and actin cytoskeleton. It is now
widely accepted that the process of cancer cells migra-
tion mainly consists of four steps: the formation and
extension of filopodium and lamellipodium at the lead-
ing edge, the establishment of new adhesion sites at the
front, contraction of cell body, and detachment of adhe-
sions at the rear [22]. Integrins play a central role in the
formation of cell adhesion to ECM. They can form het-
erodimeric receptors and integrate different extracellular
signals to downstream effectors, and then induce cell
morphological changes in adapt to the microenviron-
ment. In addition, integrins can influence cell motility
not only by providing traction forces to cell migration,
but also by regulating actin cytoskeleton remodeling and
cell contractility through active Rho GTPases [23]. Rac
is responsible for the polymerization of actin to form
peripheral lamellipodia protrusions and growth factor-
stimulated membrane ruffles, Cdc42 regulates cell polar-
ity and filopodia extension, and Rho triggers stress fibers
and cell body contraction [24,25]. Formation of focal
adhesions and the closely associated actin stress fibers
also requires the activation of the small GTP-binding
protein Rho [22,26]. Because integrins have no actin-
binding or enzymatic activities, all of downstream sig-
naling events are presumably regulated by proteins asso-
ciated with their cytoplasmic domains and molecules
they recruit [27]. For example, FAK can bind to
GTPase-activating protein (GAP) directly, modulate the
phosphorylation status of GAPs, and coordinate lamelli-
podia formation and focal adhesion turnover [28-30].
Paxillin, a focal-adhesion associated adaptor protein,
competes with p190RhoGAP for binding to p120Ras-
GAP, and p190RhoGAP freed from p120RasGAP effi-
ciently suppresses RhoA activity during cell adhesion
[31,32].
Figure 2 Knockdown of Rab5a decreases HeLa cell motility and
invasion. (A) In Control and Rab5a-siRNAs cells, the expression of
Rab5a was confirmed, and the number of the cells that invaded
through the matrigel-coated membrane was determined by
counting the cells on the lower side of the membrane under a light
microscopy (×200). (B) In Control and Rab5a-siRNAs cells, cell
motility was examined with a light microscopy (×40) at the
indicated time points, and the wounding width was quantified. MTT
data were shown in insets. The data shown represent the mean ±
S.E. (n = 3). *P < 0.05 versus Control cells, as determined by two-
tailed Student’s t test.
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Figure 3 Knockdown of Rab5a decreases SiHa cell motility and invasion. (A) In Control and Rab5a-siRNAs cells, the expression of Rab5a was
confirmed by Western blot. (B) The number of cells that invaded to the lower side of the membrane was counted under a light microscopy
(×200). (C) In Control and Rab5a-siRNAs cells, cell motility was examined with a light microscopy (×40) at the indicated time points, and the
wounding width was quantified. MTT data were shown in insets. The data shown represent the mean ± S.E. (n = 3). *P < 0.05 versus Control
cells, as determined by two-tailed Student’s t test.
Figure 4 Rab5a modulates integrin-associated focal adhesion complexes assembly in HeLa cells. (A) Levels of integrin-mediated focal
adhesion proteins in Control and Rab5a-siRNAs cells were detected by Western blot. (B and C) Control and Rab5a-siRNAs cells were stained with
integrin b1 (B) and paxillin (C) respectively.
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A key element of cell migration is the regulation of
adhesive contacts, which are dynamically assembled and
disassembled via endocytosis [19]. Adhesion molecules
is internalized at the rear and transported to the leading
edge, where they become inserted into the membrane to
form new adhesions. The depletion of Rab5a influented
the internalization and recycling of integrins from the
trailing edge to the leading edge, and interrupted the
‘outside-in’ signaling. The assembly and activities of the
downstream molecules were also disrupted, such as the
phosphorylation of FAK and paxillin. The balance
between GAPs and GEFs was changed, which led to the
down-regulation of the active GTP-bound Rho GTPases.
Thus, we observed the remodeling of the actin cytoske-
leton and impaired cell motility in Rab5a knockdown
cells. Taken together, we propose that Rab5a acts as a
regulator of integrins and their associated signaling pro-
teins, through which Rab5a can influence the cell’s
migratory machinery. Therefore, the overexpression of
Rab5a in cancer may enhance the integrin-mediated sig-
naling pathway, and induce the cancer cell migration
and invasion.
Conclusions
Here we report that Rab5a involves in the progression of
cervix cancer. Rab5a influences cancer cell motility and
invasion by regulating the expression levels and activities
of integrins and their downstream signaling molecules.
Further studies on Rab5a may help us to fully under-
stand tumor invasion and metastasis.
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